Search research articles
Contact Us
Filters
Showing results (101-110 of 165) with videos related to
Page
of 17
Sort By:
Frontiers in Public Health
|
November 7, 2022
Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021
Valentina Baccolini, Leonardo Maria Siena, Erika Renzi, et al.
Cancer Cell International
|
December 23, 2025
Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL
Marisabel Mecca, Marzia Sichetti, Enrico La Spina, et al.
Frontiers in Oncology
|
March 13, 2023
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases
Enrico La Spina, Sebastiano Giallongo, Cesarina Giallongo, et al.
Diseases (Basel, Switzerland)
|
February 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers
Vittorio Del Fabro, Lara Gullo, Giuliana Giunta, et al.
Blood
|
October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
Carlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.
Frontiers in Oncology
|
May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Biomarker Research
|
February 10, 2025
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Cancer
|
September 2, 2023
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions
Andrea Duminuco, Antonella Nardo, Alessandra Orofino, et al.
Clinical Case Reports
|
July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosis
Manlio Fazio, Calogero Vetro, Uroš Markovic, et al.
Cancers
|
July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells
Cesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 165) with videos related to
Sort By:
Page
of 17
Frontiers in Public Health
|
November 7, 2022
Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021
Valentina Baccolini, Leonardo Maria Siena, Erika Renzi, et al.
Cancer Cell International
|
December 23, 2025
Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL
Marisabel Mecca, Marzia Sichetti, Enrico La Spina, et al.
Frontiers in Oncology
|
March 13, 2023
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases
Enrico La Spina, Sebastiano Giallongo, Cesarina Giallongo, et al.
Diseases (Basel, Switzerland)
|
February 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers
Vittorio Del Fabro, Lara Gullo, Giuliana Giunta, et al.
Blood
|
October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
Carlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.
Frontiers in Oncology
|
May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Biomarker Research
|
February 10, 2025
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Cancer
|
September 2, 2023
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions
Andrea Duminuco, Antonella Nardo, Alessandra Orofino, et al.
Clinical Case Reports
|
July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosis
Manlio Fazio, Calogero Vetro, Uroš Markovic, et al.
Cancers
|
July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells
Cesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Page
of 17